Hawkins R A
Scott Med J. 1980 Apr;25(2):152-7. doi: 10.1177/003693308002500217.
Oestrogen is probably involved in breast cancer in two main ways: (1) in the aetiology of the disease as a promoting substance rather than as a carcinogen; (2) in stimulating the growth of at least some established breast cancers, acting through the oestrogen receptor. Successful modes of endocrine therapy would then be interpreted as interfering with (a) the supply of oestrogen to the tumour (b) the nuclear events in oestrogen action or (c) receptor replenishment.
(1)在疾病病因学中作为一种促进物质而非致癌物;(2)通过雌激素受体刺激至少一些已确诊的乳腺癌生长。那么,成功的内分泌治疗模式将被解释为干扰(a)肿瘤的雌激素供应,(b)雌激素作用中的核事件,或(c)受体补充。